https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-31 / J Clin Oncol 32, 2014 (suppl 3; abstr 69)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-31 / J Clin Oncol 32, 2014 (suppl 3; abstr 69)2014-07-31 12:08:122019-09-30 09:32:18The effect of stress on efficacy of dendritic cell therapy for esophageal squamous cell carcinoma.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-31 / J Clin Oncol 32, 2014 (suppl 4; abstr 189)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-31 / J Clin Oncol 32, 2014 (suppl 4; abstr 189)2014-07-31 12:07:522019-09-30 11:21:53Response of blood flow to hyperthermia in human prostate tumors: Opportunities for enhanced radiation effect and drug delivery.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-31 / J Clin Oncol 32, 2014 (suppl 4; abstr 490)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-31 / J Clin Oncol 32, 2014 (suppl 4; abstr 490)2014-07-31 11:52:432021-08-09 07:54:15A phase I, open label, dose escalation and cohort expansion study to evaluate the safety and immune response to autologous dendritic cells (DC) transduced with AdGMCA9 (DC-AdGMCAIX) in patients with mRCC.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-30 / BMC Cancer 2014 Jul;14:551
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-30 / BMC Cancer 2014 Jul;14:5512014-07-30 00:00:002014-07-30 00:00:00Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-24 / Oncol Lett 2014 Oct;8(4):1783-1787
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-24 / Oncol Lett 2014 Oct;8(4):1783-17872014-07-24 00:00:002019-04-03 11:16:21Sorafenib and locoregional deep electro-hyperthermia in advanced hepatocellular carcinoma: A phase II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-22 / J Transl Med 2014 Jul;12:209
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-22 / J Transl Med 2014 Jul;12:2092014-07-22 00:00:002019-02-15 08:48:43Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised „proof-of-principle“ phase II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-17 / Am. J. Ophthalmol. 2014 Nov;158(5):939-47
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-17 / Am. J. Ophthalmol. 2014 Nov;158(5):939-472014-07-17 00:00:002019-02-15 08:49:40Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-05 / Virology 2014 Aug;462-463:283-94
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-05 / Virology 2014 Aug;462-463:283-942014-07-05 00:00:002019-02-15 09:21:23ISG12a mediates cell response to Newcastle disease viral infection
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-03 / Nat. Rev. Cancer 2014 Aug;14(8):559-67
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-03 / Nat. Rev. Cancer 2014 Aug;14(8):559-672014-07-03 00:00:002019-02-15 09:22:39Going viral with cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-07-01 / Cancer 2014 Nov;120(21):3418-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-07-01 / Cancer 2014 Nov;120(21):3418-252014-07-01 00:00:002014-07-01 00:00:00Noninvasive radiofrequency treatment effect on mitochondria in pancreatic cancer cells
